Congestive Heart Failure
Heart disease and heart failure continues to be a large burden in the community as our patient population continues to age. Patients suffer with symptoms and debilitation with both direct and indirect costs to society. Heart failure patients have a high risk of hospital admission and readmission within 30 days of discharge. Studies have shown that multidisciplinary intervention at multiple levels have been shown to improve symptoms, decrease hospitalizations, and improve quality of life. Metropolitan Heart and Vascular Institute (MHVI) has a comprehensive program to care for patients with congestive heart failure (CHF).
The CHF Program is designed to care for patients in an outpatient/ clinic setting, working closely with the hospital, providing care and ongoing education to our patients in the hospital as well. The Heart Failure Program at MHVI offers:
- Daily open/same day appointments for patients that need to be seen on an urgent or semi-urgent basis
- Close telephone follow-up and monitoring of heart failure signs and symptoms
- One-on-one education from a CHF nurse clinician in clinic and in hospital One-on-one appointments with a clinic pharmacist to review your medications, dosage, and side effects
- Weekly calls from the CHF nurse clinician for the first 30 days after hospital discharge to help monitor heart failure symptoms and provide early intervention for any problems that may occur
- Direct phone access to a CHF nurse for questions or concerns
- Consultations with physicians specializing in treating CHF
- Referrals to CHF outpatient services, including the Cardiac Rehabilitation program, CHF support group, Home Health Care, and Advanced Care Planning sessions
- A pulmonary hypertension session, including education and close follow-up of symptoms by a specialized nurse trained in pulmonary hypertension
Heart failure specialists at MHVI work closely with other cardiovascular specialists in electrophysiology (heart rhythm management), interventional cardiology, and cardiovascular surgery to ensure that, when indicated, our patients receive adjunctive therapies such as pacemaker/defibrillators, angioplasties/stents, and surgeries, which can sometimes be highly effective in treating heart failure. We also partner with University referral centers who offer state-of-the art programs in heart transplantation and left ventricular assist devices to send our patients with advanced disease who are suitable candidates for these therapies.